Sotera Health (SHC)
12.67
-0.09 (-0.71%)
At close: Jan 15, 2025, 10:05 AM
Company Description
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally.
The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries.
The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.
Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Sotera Health
| Country | United States |
| IPO Date | Nov 20, 2020 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,000 |
| CEO | Michael B. Petras Jr. |
Contact Details
Address: 9100 South Hills Boulevard Broadview Heights, Ohio United States | |
| Website | https://soterahealth.com |
Stock Details
| Ticker Symbol | SHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001822479 |
| CUSIP Number | 83601L102 |
| ISIN Number | US83601L1026 |
| Employer ID | 47-3531161 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Michael B. Petras Jr. | Chairman & Chief Executive Officer |
| Jonathan M. Lyons | Senior Vice President & Chief Financial Officer |
| Kristin A. Gibbs | Chief Marketing Officer |
| Robert G. Hauzie | Chief Information Officer |
| Alexander Dimitrief J.D. | Senior Vice President, General Counsel & Secretary |
| Danielle J. Menture | Senior Vice President of Global Environmental, Health & Safety and Sustainability |
| Joseph A. Shrawder | President of Nelson Labs |
| Michael P. Rutz | President of Sterigenics |
| Sally R. Turner | Chief Human Resources Officer |
| William O. Lehmann Jr., J.D., M.B.A. | Senior Vice President of Strategy & Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 14, 2025 | 8-K | Current Report |
| Jan 06, 2025 | 8-K | Current Report |
| Nov 22, 2024 | 4 | Filing |
| Nov 22, 2024 | 4 | Filing |
| Nov 20, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 05, 2024 | 10-Q | Quarterly Report |
| Nov 05, 2024 | 8-K | Current Report |